Association for Accessible Medicines
FDANonrulemakingFDA-2017-D-5928

Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GDUFA

RIN
Last modified
Oct 5, 2022
Comment window
closed 3147d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Dec 18, 2017 and Dec 18, 2017. 0 other organizations filed here. The comment window closed 3147d ago.

What Association for Accessible Medicines filed (1)

Dec 18, 2017· Comment from Association for Accessible Medicines· FDA-2017-D-5928-0005

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding Docket FDA-2017-D-5928: Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GDUFA.

Abstract

No abstract recorded.

View on regulations.gov →